CoChat

Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents

Open access
Uhre, Camilla Funch, Uhre, Valdemar Funch, Lønfeldt, Nicole Nadine, Pretzmann, Linea, Vangkilde, Signe, Plessen, Kerstin Jessica, Gluud, Christian, Jakobsen, Janus Christian, Pagsberg, Anne Katrine · 2020 · Journal of the American Academy of Child & Adolescent Psychiatry
Cited by 103

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess benefits and harms of cognitive-behavioral therapy (CBT) versus no intervention or versus other interventions for pediatric obsessive-compulsive disorder (OCD). METHOD: We searched for randomized clinical trials of CBT for pediatric OCD. Primary outcomes were OCD severity, serious adverse events, and level of functioning. Secondary outcomes were quality of life and adverse events. Remission from OCD was included as an exploratory outcome. We assessed risk of bias and evaluated the certainty of the evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE). RESULTS: Nine trials (N = 645) were included comparing CBT with no intervention and 3 trials (N = 146) comparing CBT with selective serotonin reuptake inhibitors (SSRIs). Compared with no intervention, CBT decreased OCD severity (mean difference [MD] = -8.51, 95% CI = -10.84 to -6.18, p < .00001, low certainty), improved level of functioning (patient-rated: standardized MD [SMD] = -0.90, 95% CI = -1.19 to -0.62, p < .00001, very low certainty; parent-rated: SMD = -0.68, 95% CI = -1.12 to -0.23, p = .003, very low certainty), had similar proportions of participants with adverse events (risk ratio = 1.06, 95% CI = 0.93-1.22, p = .39, GRADE: low certainty), and was associated with reduced risk of still having OCD (risk ratio = 0.50, 95% CI = 0.37-0.67, p < .00001, very low certainty). We had insufficient data to assess the effect of CBT versus no intervention on serious adverse events and quality of life. Compared with SSRIs, CBT led to similar decreases in OCD severity (MD = -0.75, 95% CI = -3.79 to 2.29, p = .63, GRADE: very low certainty), and was associated with similar risk of still having OCD (risk ratio = 0.85, 95% CI = 0.66-1.09, p = .20, very low certainty). We had insufficient data to assess the effect of CBT versus SSRIs on serious adverse events, level of functioning, quality of life, and adverse events. CONCLUSION: CBT may be more effective than no intervention and comparable to SSRIs for pediatric OCD, but we are very uncertain about the effect estimates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaac.2019.08.480

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 38

  1. Heyman, 2001, Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health, Br J Psychiatry, 179, 324, 10.1192/bjp.179.4.324 · DOI · Paper page
  2. Rasmussen, 1992, The epidemiology and clinical features of obsessive compulsive disorder, Psychiatr Clin North Am, 15, 743, 10.1016/S0193-953X(18)30205-3 · DOI · Paper page
  3. Lack, 2009, Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates, Soc Psychiatry Psychiatr Epidemiol, 44, 935, 10.1007/s00127-009-0013-9 · DOI · Paper page
  4. Eisen, 2010, A 2-year prospective follow-up study of the course of obsessive-compulsive disorder, J Clin Psychiatry, 71, 10.4088/JCP.08m04806blu · DOI · Paper page
  5. Piacentini, 2003, Functional impairment in children and adolescents with obsessive-compulsive disorder, J Child Adolesc Psychopharmacol, 13, S61, 10.1089/104454603322126359 · DOI · Paper page
  6. Geller, 2012, Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder, J Am Acad child Adolescent Psychiatry, 51, 98, 10.1016/j.jaac.2011.09.019 · DOI · Paper page
  7. Abramowitz, 2006, The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis, Behav Ther, 36, 55, 10.1016/S0005-7894(05)80054-1 · DOI · Paper page
  8. McGuire, 2015, a meta-analysis of cognitive behavior therapy and medication for child obsessive-compulsive disorder: moderators of treatment efficacy, response, and remission, Depress Anxiety, 32, 580, 10.1002/da.22389 · DOI · Paper page
  9. Watson, 2008, Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder, J Child Psychol Psychiatry, 49, 489, 10.1111/j.1469-7610.2007.01875.x · DOI · Paper page
  10. Sanchez-Meca, 2014, Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis, J Anxiety Disord, 28, 31, 10.1016/j.janxdis.2013.10.007 · DOI
  11. Freeman, 2007, Cognitive behavioral treatment for young children with obsessive-compulsive disorder, Biol Psychiatry, 61, 337, 10.1016/j.biopsych.2006.12.015 · DOI
  12. O'Kearney, 2007, Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence, Aust N Z J Psychiatry, 41, 199, 10.1080/00048670601172707 · DOI
  13. Romanelli, 2014, Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials, Depress Anxiety, 31, 641, 10.1002/da.22232 · DOI · Paper page
  14. Skarphedinsson, 2015, Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons, Nord J Psychiatry, 69, 81, 10.3109/08039488.2014.941395 · DOI
  15. Ost, 2016, Cognitive behavioral and pharmacological treatments of OCD in children: a systematic review and meta-analysis, J Anxiety Disord, 43, 58, 10.1016/j.janxdis.2016.08.003 · DOI · Paper page
  16. Skapinakis, 2016, A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults, Health Technol Assess, 20, 1, 10.3310/hta20430 · DOI · Paper page
  17. Wetterslev, 2017, Trial sequential analysis in systematic reviews with meta-analysis, BMC Med Res Methodol, 17, 39, 10.1186/s12874-017-0315-7 · DOI · Paper page
  18. 1997, International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICD) adopts consolidated guideline on good clinical practice in the conduct of clinical trials on medicinal products for human use, Int Dig Health Legis, 48, 231
  19. Keus, 2010, Evidence at a glance: error matrix approach for overviewing available evidence, BMC Med Res Methodol, 10, 1, 10.1186/1471-2288-10-90 · DOI · Paper page
  20. Thorlund, 2011, Pooling health-related quality of life outcomes in meta-analysis—a tutorial and review of methods for enhancing interpretability, Res Synth Methods, 2, 188, 10.1002/jrsm.46 · DOI · Paper page
  21. DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  22. DeMets, 1987, Methods for combining randomized clinical trials: strengths and limitations, Stat Med, 6, 341, 10.1002/sim.4780060325 · DOI · Paper page
  23. Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
  24. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  25. Thorlund, 2011, 1, 1
  26. Moher, 2009, Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135 · DOI · Paper page
  27. Barrett, 2004, Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial, J Am Acad Child Adolesc Psychiatry, 43, 46, 10.1097/00004583-200401000-00014 · DOI · Paper page
  28. Bolton, 2011, Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder, J Child Psychol Psychiatry, 52, 1269, 10.1111/j.1469-7610.2011.02419.x · DOI · Paper page
  29. Williams, 2010, A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents, Eur Child Adolesc Psychiatry, 19, 449, 10.1007/s00787-009-0077-9 · DOI
  30. Freeman, 2008, Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach, J Am Acad Child Adolesc Psychiatry, 47, 593, 10.1097/CHI.0b013e31816765f9 · DOI · Paper page
  31. Freeman, 2014, Family-based treatment of early childhood obsessive-compulsive disorder: the Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)─a randomized clinical trial, JAMA Psychiatry, 71, 689, 10.1001/jamapsychiatry.2014.170 · DOI · Paper page
  32. Piacentini, 2011, Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder, J Am Acad Child Adolesc Psychiatry, 50, 1149, 10.1016/j.jaac.2011.08.003 · DOI · Paper page
  33. Asbahr, 2005, Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder, J Am Acad Child Adolesc Psychiatry, 44, 1128, 10.1097/01.chi.0000177324.40005.6f · DOI
  34. Skarphedinsson, 2015, Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial, European Child and Adolescent Psychiatry, 24, 591, 10.1007/s00787-014-0613-0 · DOI · Paper page
  35. O'Kearney, 2006, Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents, Cochrane Database Syst Rev, 4, CD004856
  36. Wilens, 2003, A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors, J Child Adolesc Psychopharmacol, 13, 143, 10.1089/104454603322163862 · DOI · Paper page
  37. Altman, 2006, The cost of dichotomising continuous variables, BMJ, 332, 1080, 10.1136/bmj.332.7549.1080 · DOI · Paper page
  38. Macpherson, 2016, The relationship between clinical and recovery dimensions of outcome in mental health, Schizophr Res, 175, 142, 10.1016/j.schres.2015.10.031 · DOI · Paper page

Cited by

Metadata

Authors
Uhre, C. F., Uhre, V. F., Lønfeldt, N. N., Pretzmann, L., Vangkilde, S., Plessen, K. J., Gluud, C., Jakobsen, J. C., & Pagsberg, A. K.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2020-01
Volume
59
Issue
1
Pages
64-77
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2978166295
Cited by
103
References
15
FWCI
1.81
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.